FITC-Linked Monoclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
Uniprot
P50591
Field of Research
Apoptosis; Tumor immunity
Applications
WB; IHC; ICC; IF.
Organism Species
Homo sapiens (Human)
Concentration
1mg/mL
Buffer
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Host
293F Cells
Source
Antibody labeling
Recommended Usage
Western blotting: 0.2-2µg/mL;1:500-5000 Immunohistochemistry: 5-20µg/mL;1:50-200 Immunocytochemistry: 5-20µg/mL;1:50-200 Optimal working dilutions must be determined by end user.
